Moura Andre V. 4
4 · Bellerophon Therapeutics, Inc. · Filed Sep 26, 2017
Insider Transaction Report
Form 4
Moura Andre V.
Director
Transactions
- Award
Stock Option (right to buy)
2017-09-22+10,000→ 10,000 totalExercise: $1.12Exp: 2027-09-21→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]This option was granted on September 22, 2017. This option vests in three equal annual installments over a three-year period from the date of grant.